P2B-004

University of Iowa (Iowa City, IA) › P2B-004

P2B-004

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
University of Iowa (Iowa City, IA) · Dr. Okafor
consented 2012-03-23

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 weight decreased with onset in cycle 6 (2012-07-31); assessed as not related to study drug (not related); resolved 2012-09-13.

moderate assessed

Grade 2 anaemia with onset in cycle 4 (2012-06-25); assessed as related to study drug (probable); resolved 2012-07-20.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.